WallStSmart
PBM

Psyence Biomedical Ltd. Common Shares

NASDAQ: PBM · HEALTHCARE · BIOTECHNOLOGY

$5.40
+8.65% today

Updated 2026-09-11

Market cap
$16.06M
P/E ratio
P/S ratio
EPS (TTM)
$-12.83
Dividend yield
52W range
$2 – $35
Volume
0.1M

WallStSmart proprietary scores

23
out of 100
Grade: F
Strong Sell
Investment rating
4.3
Growth
C
7.3
Quality
B+
3.0
Profitability
D
5.0
Valuation
C+
2/9
Piotroski F-Score
Weak
10.5
Altman Z-Score
Safe zone
Industry rank
View all highly rated stocks (75+) →251 stocks currently score above 75

Price targets

Analyst target
12-Month target
Intrinsic (DCF)
Margin of safety

Price chart

Stock snapshot

Strengths
+ Altman Z 10.54 — safe zone
Risks
- Piotroski 2/9 — weak financial health
- Thin margins at 0.00%
- Negative free cash flow $-8.64M

Key financials

Revenue Net Income Free Cash Flow
Metric2023202420252026TTM
Revenue$0.00$0.00$0.00$0.00$0.00
Net income$8.01M$-51.16M$1.01M$-6.94M$-6.94M
EPS$-12.83
Free cash flow$-2153.00$-2.95M$-3.74M$-8.64M$-8.64M
Profit margin

Peer comparison

CompanyMkt CapScoreGrowthProfitValueQualityMoSRating
PBM$16.06M234.33.05.07.3Avoid
LLY$994.92B769.310.05.06.0Strong Buy
JNJ$640.02B594.78.52.76.0-88.93%Buy
ABBV$454.36B736.78.54.05.0-69.36%Strong Buy
MRK$355.10B364.04.52.05.0-73.74%Hold
UNH$340.27B627.35.54.76.0-16.10%Buy

Smart narrative

Psyence Biomedical Ltd. Common Shares trades at $5.40. Our Smart Value Score of 23/100 indicates the stock is weak. The company scores 2/9 on the Piotroski F-Score. With an Altman Z-Score of 10.54, it sits in the safe zone.

Frequently asked questions

What is Psyence Biomedical Ltd. Common Shares's stock price?

Psyence Biomedical Ltd. Common Shares (PBM) trades at $5.40.

Is Psyence Biomedical Ltd. Common Shares overvalued?

Psyence Biomedical Ltd. Common Shares carries a Smart Value Score of 23/100 (Grade F), which we rate Strong Sell. That score blends growth, quality, and valuation into one read.

Altman Z-Score?

Psyence Biomedical Ltd. Common Shares's Altman Z-Score is 10.54, which places it in the safe zone. The Altman Z-Score gauges bankruptcy risk from profitability, leverage, and asset efficiency, and a higher reading points to lower financial distress risk.

Company info

SectorHEALTHCARE
IndustryBIOTECHNOLOGY
CountryUSA
ExchangeNASDAQ
CurrencyUSD

Quick metrics

P/S ratio
ROE-74.30%
Beta1.73
50D MA$3.43
200D MA$13.84
Shares out0.00B
Float0.00B
Short ratio
Avg volume0.1M

Performance

1 week
1 month
3 months
YTD
1 year
3 years
5 years